Seroprevalence of Toxoplasmosis and impact on obstetric complications in pregnant women treated at the San Isidro Maternal and Child Center, period 2023
DOI:
https://doi.org/10.62305/biosana.v4i2.198Keywords:
Abortion; pregnancy; prevention.Abstract
Toxoplasmosis, a parasitic infection, can have adverse consequences during pregnancy. The objective of this study was to evaluate the seroprevalence of toxoplasmosis and impact on obstetric complications in pregnant women treated at the San Isidro Maternal and Child Center, period 2023. A retrospective study was carried out using data obtained from the institution's obstetrics area program. The results showed that the IgG antibody obtained a frequency of 9%, due to previous exposure to the parasite, the IgM antibody obtained a lower frequency of 3%, while the majority of pregnant women have a negative result for both antibodies (88 %). Among the most relevant complications that were obtained were lymphadenopathy, weakness and headache (2%). Among the relationship of seroprevalence with complications, headache predominated in the IgG antibody in 4 pregnant women, abortion and lymphadenopathy occurred in the IgM antibody in one pregnant woman, in total 14 complications were evident in relation to the seroprevalence of toxoplasmosis. In conclusion, this study highlighted the importance of early detection and specialized care for HIV-positive pregnant women, in order to reduce the risk of complications and promote healthy outcomes for the mother and baby during and after pregnancy.
Downloads
References
Anaylle L, Bruno W, Jose S, Thayla L, Anne C MA. Fatores relacionados com a suscetibilidade e transmissibilidade da toxoplasmose em gestantes. Uma revisão sistemática. In: Investigación, Sociedad y Desarrollo. 2023. p. 6. Available from: https://rsdjournal.org/index.php/rsd/article/view/42249/34147
Ollos Méndez, J., Ruiz Plúas, G., Roca Castillo, H., & Olvera Morán Y. Abordaje de diagnóstico y terapéutico de la toxoplasmosis congénita. In: Journal of American Health. 2021. p. 3. Available from: https://jah-journal.com/index.php/jah/article/view/74/159
Rolon Lopez, Julio Cesar; Marcial González G. SEROPREVALENCIADETOXOPLASMOSISENEMBARAZADASQUEACUDENALSERVICIODEGINECO-OBSTETRICIADELHOSPITALCENTRALDELINSTITUTODEPREVISIÓNSOCIAL,2016. Arandu Poty. 2023;1:5. Available from: https://www.revistarandupoty.com/index.php/AranduPoty/article/view/71/53
Concepción IP, Prado Quilambaqui JV, Ramírez López LR, Padilla CP. Prevalence of Toxoplasma gondii in asymptomatic pregnant women in Quito, Ecuador 2020. Bol Malariol y Salud Ambient. 2021;61(3):436–42. Available from: https://docs.bvsalud.org/biblioref/2022/12/1401435/338-1606-1-pb.pdf
Alex Javier Criollo Rodríguez, Segundo Moisés San Lucas Coque, Zaihrys Del Carmen Herrera Lazo RRD. eroprevalencia y factores de riesgo de la infección por Toxoplasma gondii en mujeres embarazadas. Boletín Malariol y Salud Ambient. 2023;63:1. Available from: http://iaes.edu.ve/iaespro/ojs/index.php/bmsa/article/view/679
Angela María Bracho Mora. Qhalikay. 2022;6:2. Available from: https://revistas.utm.edu.ec/index.php/QhaliKay/article/view/4438
Heber Silva-Díaz, Emma V. Arriaga-Deza, Virgilio E. Failoc-Rojas, Yessica R. Alarcón-Flores, Sara Y. Rojas-Rojas, Lizzie K. Becerra-Gutiérrez, Katya M. Mera-Villasis, Franklin R. Aguilar-Gamboa and TS-G. Seroprevalence of toxoplasmosis in pregnant women and its associated factors among hospital and community populations in Lambayeque, Peru. 2020;53:6. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7094055/
Rafael C, Solange M, Santiago C, Marta S, Arantxa R, Gema A LO. Anticuerpos anti- Toxoplasma gondii en residentes europeos: una revisión sistemática y un metanálisis de estudios publicados entre 2000 y 2020. MDPI. 2023;12:12. Available from: https://www.mdpi.com/2076-0817/12/12/1430
Paola S , Alessandro M, Patrizio P, Cecilia F, Arianna N, Paola V, Fabio V FP. Aumento de la incidencia de enfermedad meningocócica invasiva del serogrupo C/complejo clonal 11, Toscana, Italia, 2015 a 2016. Eurosurveillance. 2020;21:12. Available from: http://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2016.21.12.30176
Majda L, Zoubida T O, S FP and A. Toxoplasma gondii seroprevalence among pregnant women in Rabat, Morocco. Trop Med Health. 2021;49:21. Available from: https://link.springer.com/article/10.1186/s41182-021-00311-5
Michele T, Alessandra T, Elisa S SG. Primary toxoplasmosis acquired during early pregnancy: Is it currently overestimated. Elsevier. 2021;267:285–9. Available from: https://www.sciencedirect.com/science/article/abs/pii/S0301211521005649
Nurul F AP. Seroprevalence and associated risk factors of Toxoplasma gondii infection among pregnant mother in Makassar, Indonesia. Vol. 9, Plos One. 2021. Available from: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0245572
Magalie D, Célia D, Nicolas G V V. Retrospective study of toxoplasmosis prevalence in pregnant women in Benin and its relation with malaria. Pubmed. 2022;17:1. Available from: https://pubmed.ncbi.nlm.nih.gov/34995295/
Karl W, Lucille P, Martin L LM. Hygiene measures as primary prevention of toxoplasmosis during pregnancy: A systematic review. Elsevier. 2022;51:3. Available from: https://www.sciencedirect.com/science/article/abs/pii/S2468784721002361
Felín MS, Wang K, Moreira A, Grose A, Leahy K, Zhou Y, et al. Building Programs to Eradicate Toxoplasmosis Part IV: Understanding and Development of Public Health Strategies and Advances “Take a Village.” Curr Pediatr Rep. 2022;10(3):125–54. Available from: https://link.springer.com/content/pdf/10.1007/s40124-022-00268-x.pdf
Midori H, Ichiro M, Aya O NM. A prospective cohort study of newborns born to mothers with serum Toxoplasma gondii immunoglobulin M positivity during pregnancy. Elsevier. 2022;28:486–91. Available from: https://www.sciencedirect.com/science/article/abs/pii/S1341321X2100341X
Cedeño P, Sarango B SP. Toxoplasmosis en embarazadas en el centro de salud Puerto Bolívar perspectiva enfermería Machala-Ecuador. Dialnet. 2023;8:4. Available from: https://dialnet.unirioja.es/servlet/articulo?codigo=9152221
Guerrero A, Núñez D, Benítez G, Alfonso O, Portillo C, Http://orcid.org/0009-0008-0384-984X JR, et al. Toxoplasmosis en el embarazo: Características epidemiológicas, clínicas y laboratoriales en un centro de referencia. Rev del Inst Med Trop. 2023;18(1):12–20. Available from: http://scielo.iics.una.py/pdf/imt/v18n1/1996-3696-imt-18-01-12.pdf
Karen. T. SÍNDROME TORCH: ENFOQUE RACIONAL DEL DIAGNÓSTICO Y TRATAMIENTO PRE Y POST NATAL EN EL ECUADOR. SOCIENCYTEC. 2023;1:1. Available from: https://sociencytec.com/index.php/sct/article/view/11/10
Sara F, Fabio P, Mosaniel F, Walmirton B, Erica E MG. Prevalência de soropositividade para Toxoplasma gondii em gestantes de Gurupi — estado do Tocantins. Rev Gestão e Secr. 2023;14:5. Available from: https://ojs.revistagesec.org.br/secretariado/article/view/2111
Jesus A JB. Determinación de la Frecuencia de Toxoplasmosis Gestacional en Mujeres en Zona de Frontera Atendidas en CEDMI, en el año 2023. In 2023. p. 88–100. Available from: https://repositorio.udes.edu.co/server/api/core/bitstreams/437699a7-b028-4857-ab14-25408013a11e/content
Sumit K. Matta, Nicholas Rinkenberger IRD& LDS. Toxoplasma gondii infection and its implications within the central nervous system. In: Nature Reviews Microbiology. 2021. p. 1. Available from: https://www.nature.com/articles/s41579-021-00518-7
Milde, G..Wesbter, J., Walker M. Toxoplasma gondii: An Underestimated Threat? In: Trends in Parasitology. 2020. p. 69. Available from: https://www.cell.com/trends/parasitology/fulltext/S1471-4922(20)30221-X
Isabel Gonzalez. Libro de resumenes. 2023. 3 p. Available from: https://burjcdigital.urjc.es/bitstream/handle/10115/21989/978-84-09-50969-0.pdf?sequence=1&isAllowed=y
Yin W JC. Toxoplasmosis congénita: epidemiología, manifestaciones clínicas y diagnóstico de laboratorio. Rev Multidiscip Arbitr Investig científica. 2023;7:2. Available from: https://www.investigarmqr.com/ojs/index.php/mqr/article/view/404
Alonso A, Travis L, Michelle B HD. The One Health Approach to Toxoplasmosis: Epidemiology, Control, and Prevention Strategies. Ecohealth. 2019;16:378–90. Available from: https://link.springer.com/article/10.1007/s10393-019-01405-7?eType=EmailBlastContent
Espinoza Rojas, J.., Lopez Mora, E.. Dabanch Peña, J.., Cruz Choapa R. Recomendaciones para el diagnóstico y tratamiento de la infección por Toxoplasma gondii. In 2022. p. 132. Available from: https://www.scielo.cl/scielo.php?pid=S0716-10182022000200132&script=sci_arttext
S/A. Prospective evalution of pregnant women with suspected acute toxoplasmosis treated in a reference prenatal care clinic at a university teaching hospital in Southern Brazil. Rev del Inst Med Trop São Paulo. 2020;62. Available from: https://www.scielo.br/j/rimtsp/a/Rq6h7yBmSVWjCPQBbksz76S/?format=html&lang=en
Ocaña N, Paredes A, Fuertes R, Pazmiño E. Toxoplasmosis congénita diagnóstico y tratamiento. Rev Cient Mundo la Investig y el Conoc. 2020;4(3):118–27. Available from: https://www.recimundo.com/index.php/es/article/view/855/1556
Durlach R, Freuler C, Messina M, Freilij H, Ayala SG, Venturini C, et al. Consenso argentino de toxoplasmosis congénita 2020. Med Buenos Aires. 2021;81(2):257–68. Available from: http://www.medicinabuenosaires.com/PMID/33906145.pdf
Abhishek M, Shreya S, Sumeeta K, Parakriti G RS. Seroprevalence of Toxoplasmosis at a Tertiary Care Centre in North India from 2004 to 2014. Elsevier. 2019;37:351–7. Available from: https://www.sciencedirect.com/science/article/pii/S0255085720312846?via%3Dihub
Thiermann, Erika; Atías, Antonio; Lorca M. Apreciaciones sobre el riesgo relativo de la transmisión de la toxoplasmosis por transfusión sanguínea. In: Portal Regional da BVS. 2021. p. 1. Available from: https://pesquisa.bvsalud.org/portal/resource/pt/lil-58829
Stiward Mauricio Velasco Jácome1, Andrea Suarez Chamorro2, Maite Pame-la Rosero Perlaza3, Angie Heeyzarath Zhune Gallegos4 NJPV. Toxoplasmosis en el embarazo. In: Revista La U Investiga. 2023. p. 5. Available from: https://revistasojs.utn.edu.ec/index.php/lauinvestiga/article/view/857/830
N. A de CE. La educación en salud como herramienta prenatal: información para mujeres embarazadas sobre la prevención de la toxoplasmosis congénita. Rev Contrib a las ciencias Soc. 2024;17:01–19. Available from: https://ojs.revistacontribuciones.com/ojs/index.php/clcs/article/view/5355/3510
Condori V, Cruz J, Loza M. Toxoplasmosis ocular. Una visión general durante el embarazo. 2020;26–38. Available from: file:///C:/Users/Home/Downloads/648-Texto del artículo-1239-1-10-20210511.pdf
Ubaldo Zavaleta EL. Factores Asociados y Frecuencia de Toxoplasmosis en Gestantes Atendidas en el Hospital Nacional Docente Madre Niño San Bartolomé, Lima 2020 – 2022. In: Norbert wiener. 2023. p. 26. Available from: https://repositorio.uwiener.edu.pe/bitstream/handle/20.500.13053/10533/T061_46860194_T.pdf?sequence=1&isAllowed=y
Pantoja-Ruiz C, Martinez A, Ferreiros A, Millán S, Coral J. Toxoplasmosis en sistema nervioso central: revisión sobre la patología, abordaje diagnóstico y tratamiento. Acta Neurológica Colomb. 2021;37(1 Supl 1):141–7. Available from: http://www.scielo.org.co/pdf/anco/v37n1s1/2422-4022-anco-37-01-s1-141.pdf
Daniel V SK. INFECCIONES DE REPERCUSIÓN EMBRIONARIA Y FETAL. GinecoFlasog. 2019;1:11. Available from: https://flasog.org/wp-content/uploads/2022/03/REVISTA-FLASOG-NO2_compressed.pdf
Alfonso Stumpfs,O.., Gibert Rolón,W.., Escumbarti Morcillo, C.., Navarro Gómez, L.., Arrúa Aveiro, D.., Portillo Delvalle C. Amniocentesis en gestantes con toxoplasmosis. In: Revista Oficial. 2022. p. 2. Available from: https://revistafpgo.org/index.php/rvfpgo/article/view/2/2
Gavito DEG, Álvarez HH, Fernández FAN, Arias PC, De-La-torr A. Primoinfection by Toxoplasma gondii in pregnant women in Primary Health Care in Havana. Rev Cubana Med Trop. 2022;74(1). Available from: https://www.medigraphic.com/pdfs/revcubmedtro/cmt-2022/cmt221i.pdf
Mabel Torres., Y, Antonela S. BIOMEDICINA TOXOPLASMOSIS PREVENCIÓN TRATAMIENTO SEROPREVALENCIA. In: Repositorio Digital. 2023. p. 10. Available from: https://repositorio.uisek.edu.ec/handle/123456789/5012
A, Bracho., F, Tumbaco., J, Ormaza., Z, Rivero., I V. Factores de riesgo para la infección por Toxoplasma gondiien embarazadas que asisten al Centro de Salud tipo C, Manta,Ecuador. In: Qhalikay, revista de ciencias de la salud. 2022. p. 11. Available from: https://revistas.utm.edu.ec/index.php/QhaliKay/article/view/4438/5230
Clemenza, C., Gotera, A. y Araujo R. Scielo. Ve.Scielo.Org. Vol. 36, Técnica de la Facultad de Ingeniería Universidad del Zulia. 2022. Available from: http://ve.scielo.org/scielo.php?script=sci_arttext&pid=S0798-02642007000200002
A, Lopez., J, Diaz., J G. Factores de Riesgo en mujeres embarazadas, infectadas por. Methods. 2020;7(2):180–90. Available from: https://www.scielosp.org/pdf/rsap/2005.v7n2/180-190/es
Centro para el control y prevención de Enfermedades. Centros para el Control y la Prevención de Enfermedades. 2022. Available from: https://www.cdc.gov/dpdx/toxoplasmosis/index.html
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 BIOSANA Health Scientific Journal. ISSN 2960-8481
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
